## Mechanism Analysis of Antiepileptics ### Correct Mechanisms **Key Point:** Phenytoin's primary mechanism is sodium channel blockade, which stabilizes the neuronal membrane and prevents repetitive firing. It does NOT significantly enhance GABA activity. **Key Point:** Valproic acid (VPA) increases GABA levels through two pathways: 1. Inhibition of GABA transaminase (the enzyme that degrades GABA) 2. Increased glutamic acid decarboxylase (GAD) activity **Key Point:** Levetiracetam (LEV) is unique — it binds to the synaptic vesicle protein SV2A, which modulates vesicular neurotransmitter release. This is distinct from sodium/potassium channel effects. ### Why Lamotrigine's Mechanism is Misrepresented **High-Yield:** Lamotrigine's PRIMARY mechanism is **sodium channel blockade** (like phenytoin), NOT enhancement of GABA release. While lamotrigine does have some indirect GABAergic effects, its main action is stabilization of neuronal membranes via Na^+^ channel inhibition. The option incorrectly pairs two separate drug mechanisms. ### Mechanism Comparison Table | Drug | Primary Mechanism | Secondary Mechanism | |------|-------------------|---------------------| | Phenytoin | Na^+^ channel blockade | — | | Valproic acid | GABA ↑ (↓ GABA-T) | Histone deacetylase inhibition | | Lamotrigine | Na^+^ channel blockade | Weak GABA↑, glutamate↓ | | Levetiracetam | SV2A binding | Modulation of neurotransmitter release | **Clinical Pearl:** Lamotrigine is often confused with GABA-enhancing drugs because it is used in bipolar disorder (where GABAergic stabilization helps), but its anticonvulsant action is primarily through sodium channel inhibition, not GABA enhancement. **Mnemonic: "GABA Boosters"** — VPA and benzodiazepines enhance GABA; lamotrigine and phenytoin block sodium channels.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.